What's Behind Regeneron Pharmaceuticals' Great Q4 Results

·

·

What's Behind Regeneron Pharmaceuticals' Great Q4 Results

Sure, Regeneron Pharmaceuticals’ (NASDAQ:REGN) stock performance in 2019 was anemic. And, yes, heading into its fourth-quarter update the biotech hadn’t excited investors so far in 2020. But Regeneron changed the story when it announced its 2019 …
See Original Article

Kellogg Shares Plunge on Weakening Profits: Where Does It Go From Here?

The cereal and snacks conglomerate presented a surprisingly soft earnings picture to shareholders on Thursday. Asit Sharma. (TMFfinosus). Feb 6, 2020 at 2:25PM. Author Bio. Midnight oil burners, unite! I’m a CPA & CMA (Certified Management Accountant) …
See Original Article

First genetically-edited cancer treatment shown to be safe

Immune cells were taken from cancer patients, edited to make them better at fighting cancer, and replaced. By Sarah Knapton, Science Editor 6 February 2020 • 7:00pm. Premium. Crispr acts like genetic scissors, snipping away parts of the DNA Credit: Getty.
See Original Article

Mercedes-Benz brings back the camper van with its new Weekender

An SUV might look like a great way to escape the grind of city life, but it will be pretty uncomfortable to sleep in. That’s why Mercedes-Benz has unveiled the Weekender, a classic style pop-up camper van that sleeps four. The Weekender is based on …
See Original Article

Uber and Lyft cars become vector for racism amid coronavirus fears

As the deadly coronavirus spreads beyond China, the ensuing panic is inflaming bigotry against people of Asian descent around the world. One venue where that’s playing out is in the backseats of Uber and Lyft cars. In interviews and online, customers and …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.